Appili Therapeutics Inc. (TSX:APLI)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Jul 16, 2026, 4:10 PM EST
Appili Therapeutics Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 0.24 | 0.1 | 0.83 | 0.33 | 1.39 | |
Revenue Growth (YoY) | 143.10% | -87.86% | 147.59% | -75.97% | - |
Gross Profit | 0.24 | 0.1 | 0.83 | 0.33 | 1.39 |
Selling, General & Admin | 2.47 | 2.85 | 3.05 | 4.44 | 4.61 |
Research & Development | 4.29 | 7.32 | 5.62 | 3.62 | 20.74 |
Other Operating Expenses | 2.71 | 9.9 | 6.1 | 0.32 | 1.77 |
Total Operating Expenses | 9.47 | 20.08 | 14.77 | 8.39 | 27.13 |
Operating Income | -9.23 | -19.98 | -13.94 | -8.05 | -25.74 |
Interest Income | - | 0 | 0.02 | 0.03 | 0.03 |
Interest Expense | -1.01 | -3.5 | -1.63 | -1.1 | -1.55 |
Other Non-Operating Income (Expense) | 0.27 | 1.74 | -0.07 | 0.36 | -0.06 |
Total Non-Operating Income (Expense) | -0.74 | -1.76 | -1.68 | -0.7 | -1.58 |
Pretax Income | -9.97 | -21.74 | -15.62 | -8.75 | -27.32 |
Provision for Income Taxes | 0.11 | 0.02 | 0.07 | 0.04 | 0.04 |
Net Income | -10.07 | -21.75 | -15.69 | -8.79 | -27.36 |
Net Income to Common | -4.24 | -2.62 | -3.78 | -9.24 | -25.12 |
Shares Outstanding (Basic) | 124 | 121 | 121 | 114 | 67 |
Shares Outstanding (Diluted) | 124 | 121 | 121 | 114 | 67 |
Shares Change (YoY) | 2.02% | - | 6.62% | 70.43% | 12.76% |
EPS (Basic) | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 |
EPS (Diluted) | -0.03 | -0.02 | -0.03 | -0.08 | -0.38 |
Free Cash Flow | -1.34 | 0.87 | -2.49 | -10.1 | -19.08 |
Free Cash Flow Per Share | -0.01 | 0.01 | -0.02 | -0.09 | -0.29 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -3779.42% | -19891.20% | -1684.49% | -2409.73% | -1851.00% |
Profit Margin | -4125.81% | -21658.90% | -1895.93% | -2630.56% | -1967.23% |
FCF Margin | -547.72% | 862.63% | -301.44% | -3022.65% | -1372.07% |
EBITDA | -9.22 | -19.97 | -13.92 | -8.05 | -25.73 |
EBITDA Margin | -3776.11% | -19877.80% | -1682.84% | -2407.85% | -1850.09% |
EBIT | -9.23 | -19.98 | -13.94 | -8.05 | -25.74 |
EBIT Margin | -3779.42% | -19891.20% | -1684.49% | -2409.73% | -1851.00% |
Effective Tax Rate | -1.06% | -0.09% | -0.45% | -0.42% | -0.14% |